Bendamustine as an alternative to BCNU as conditioning regimen for autologous stem cell transplantation in patients with aggressive lymphoma: Results phase 2 study from GELTAMO

被引：0

作者：

Maria Redondo, Alba ^{[1
]}

Valcarcel, D. ^{[2
]}

Gonzalez, A. P. ^{[3
]}

Suarez-Lledo, M. ^{[4
]}

Bello, J. L. ^{[5
]}

Canales, M. ^{[6
]}

Gayoso, J. ^{[7
]}

Conde, E. ^{[8
]}

Jarque, I. ^{[9
]}

Del Campo, R. ^{[10
]}

Arranz, R. ^{[11
]}

Terol, M. J. ^{[12
]}

Rifon, J. J. ^{[13
]}

Rodriguez, M. J. ^{[14
]}

Ramirez, M. J. ^{[15
]}

Castro, N. ^{[16
]}

Sanchez, A. ^{[17
]}

Lopez-Jimenez, J. ^{[18
]}

Briones, J. ^{[19
]}

Lopez, A. ^{[20
]}

Palomera, L. ^{[21
]}

Baile, M. ^{[1
]}

Caballero, Dolores ^{[1
]}

Martin, Alejandro ^{[1
]}

机构：

[1] Hosp Univ Salamanca IBSAL, Hematol, Salamanca, Spain

[2] Hosp Valle De Hebron, Hematol, Barcelona, Spain

[3] Hosp Cent Asturias, Hematol, Oviedo, Spain

[4] Hosp Clin Barcelona, Hematol, Barcelona, Spain

[5] Complejo Hosp Univ Santiago de Compostela, Hematol, Santiago De Compostela, Spain

[6] Hosp Univ La Paz, Hematol, Madrid, Spain

[7] Hosp Gen Univ Gregorio Maranon, Hematol, Madrid, Spain

[8] Hosp Univ Marques Valdecilla, Hematol, Santander, Spain

[9] Hosp Univ Fe, Hematol, Valencia, Spain

[10] Hosp Son LLatzer, Hematol, Palma De Mallorca, Spain

[11] Hosp Princesa, Hematol, Madrid, Spain

[12] Hosp Univ Valencia, Hematol, Valencia, Spain

[13] Clin Univ Navarra, Hematol, Pamplona, Spain

[14] Hosp Univ Canarias, Hematol, San Cristobal La Laguna, Spain

[15] Hosp Jerez, Hematol, Jerez de la Frontera, Spain

[16] Hosp 12 Octubre, Hematol, Madrid, Spain

[17] Hosp Virgen de la Arreixaca, Hematol, Murcia, Spain

[18] Hosp Ramon & Cajal, Hematol, Madrid, Spain

[19] Hosp Santa Creu & Sant Pau, Hematol, Barcelona, Spain

[20] Hosp Arnau de Villanoba, Hematol, Valencia, Spain

[21] Hosp Clin Zaragoza, Hematol, Zaragoza, Spain

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P157

引用

页码：261 / 262

页数：2

共 50 条

[1] Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
Redondo, Alba M.
Valcarce, David
Gonzalez-Rodriguez, Ana P.
Suarez-Lledo, Maria
Bello, Jose L.
Canales, Miguel
Gayoso, Jorge
Colorado, Mercedes
Jarque, Isidro
del Campo, Raquel
Arranz, Reyes
Terol, Maria J.
Rifon, Jose J.
Rodriguez, Maria J.
Ramirez, Maria J.
Castro, Nerea
Sanchez, Andres
Lopez-Jimenez, Javier
Montes-Moreno, Santiago
Briones, Javier
Lopez, Aurelio
Palomera, Luis
Lopez-Guillermo, Armando
Caballero, Dolores
Martin, Alejandro
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 797 - 807
[2] A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis
Martin, Alejandro
Maria Redondo, Alba
Valcarcel, David
Pilar Gonzalez, Ana
Lopez-Guillermo, Armando
Luis Bello, Jose
Canales, Miguel A.
Gayoso, Jorge
Conde, Eulogio
Jarque, Isidro
Del Campo, Raquel
Arranz, Reyes
Terol, Maria-Jose
Rifon, Jose J.
Rodriguez, Maria-Jose
Ramirez, Maria-Jose
Grande, Carlos
Sanchez, Andres
Lopez-Jimenez, Javier
Caballero, Dolores
BLOOD, 2014, 124 (21)
[3] Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
Shabbir-Moosajee, Munira
Jehangir, Samad
Sawani, Sobiya
Muhammed, Tariq
Ali, Natasha
Sheikh, Usman
Adil, Salman
BLOOD RESEARCH, 2019, 54 (02) : 108 - 113
[4] Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma
Boisjoly, Josie-Anne
Bouchard, Philippe
Cohen, Sandra
Ahmad, Imran
Bambace, Nadia M.
Bernard, Lea
Delisle, Jean-Sebastien
Kiss, Thomas L.
Roy, Denis-Claude
Sauvageau, Guy
Roy, Jean
Lachance, Silvy
BLOOD, 2017, 130
[5] Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation
Huang, Haiwen
Zhang, Lihong
Jiang, Yibin
Liu, Shuo
Jin, Zhengming
Chen, Jia
Xiao, Xiaofang
Ruan, Jia
Zhang, Xinyou
Wu, Depei
ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1259 - 1266
[6] Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation
Haiwen Huang
Lihong Zhang
Yibin Jiang
Shuo Liu
Zhengming Jin
Jia Chen
Xiaofang Xiao
Jia Ruan
Xinyou Zhang
Depei Wu
Annals of Hematology, 2019, 98 : 1259 - 1266
[7] Pharmacoeconomic Impact and Transplant Outcome Associated to Carmustine (BCNU) Substitution with Bendamustine (Be) in the Conditioning Regimen Prior to Autologous Stem Cell Transplantation for Lymphoma Treatment
Boisjoly, Josie-Anne
Bouchard, Philippe
Ahmad, Imran
Bambace, Nadia M.
Bernard, Lea
Cohen, Sandra
Delisle, Jean-Sebastien
Kiss, Thomas L.
Roy, Denis-Claude
Sauvageau, Guy
Roy, Jean
Lachance, Silvy
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S129 - S130
[8] BTM: an alternative conditioning regimen for autologous stem cell transplantation
De Rosa, G.
Morelli, E.
Montante, B.
De Rosa, A.
Rotoli, B.
BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
[9] BCNU-EAM vs non-BCNU alternative alkylator -EAM conditioning regimens for autologous stem cell transplantation in lymphoma patients
Sahin, Deniz Goren
Cengiz, Guldane Seval
Soydan, Ender
Ozcelik, Emine Tulay
Gokmen, Ayla
Gokgoz, Zafer
Topcuoglu, Pervin
Arslan, Onder
Gurman, Gunhan
Ozcan, Muhit
Arat, Mutlu
BONE MARROW TRANSPLANTATION, 2018, 53 : 256 - 257
[10] Comparison of Safety and Efficacy of Bendamustine versus Carmustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractoy lymphoma
Moosajee, Munira
Jehangir, Samad
Sawani, Sobia
Tariq, Wajeeha
Ali, Natasha
Sheikh, Mohammed Usman
Adil, Salman
BONE MARROW TRANSPLANTATION, 2018, 53 : 269 - 269

← 1 2 3 4 5 →